↓ Skip to main content

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

Overview of attention for article published in Radiation Oncology, June 2012
Altmetric Badge

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
Published in
Radiation Oncology, June 2012
DOI 10.1186/1748-717x-7-99
Pubmed ID
Authors

Michael C Kreissl, Heribert Hänscheid, Mario Löhr, Frederik A Verburg, Markus Schiller, Michael Lassmann, Christoph Reiners, Samuel S Samnick, Andreas K Buck, Michael Flentje, Reinhart A Sweeney

Abstract

External beam radiotherapy (EBRT) is the treatment of choice for irresectable meningioma. Due to the strong expression of somatostatin receptors, peptide receptor radionuclide therapy (PRRT) has been used in advanced cases. We assessed the feasibility and tolerability of a combination of both treatment modalities in advanced symptomatic meningioma.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Student > Ph. D. Student 7 12%
Student > Bachelor 6 10%
Student > Master 6 10%
Student > Doctoral Student 3 5%
Other 9 16%
Unknown 18 31%
Readers by discipline Count As %
Medicine and Dentistry 23 40%
Nursing and Health Professions 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Physics and Astronomy 3 5%
Agricultural and Biological Sciences 2 3%
Other 5 9%
Unknown 18 31%